Quick-relief medications (rescue medications) Taken as needed for rapid, short-term relief of symptoms - used to prevent or treat an asthma attack. Short-acting beta agonists such as albuterol. Ipratropium (Atrovent) Oral and intravenous corticosteroids (for serious asthma attacks)
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Asthma Medication industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Quick-Relief Medications
Long-Term Control Medications
Asthma Medications During Pregnancy
Market Segment by Product Application
Children
Adolescent
Adult
Finally, the report provides detailed profile and data information analysis of leading company.
Dulera
QVAR
Glaxosmithkline plc
MAP Pharmaceuticals,Inc
Merck & Co. Inc
AstraZeneca plc
Roche Holdings Ltd
Genentech Inc
Sepracor, Inc
Schering-Plough Corp
Sanofi-Aventis
Theravance Inc
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Asthma Medication consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Asthma Medication market by identifying its various subsegments.
3.Focuses on the key global Asthma Medication manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Asthma Medication with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Asthma Medication submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Asthma Medication Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Asthma Medication Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Asthma Medication Segment by Type
2.1.1 Quick-Relief Medications
2.1.2 Long-Term Control Medications
2.1.3 Asthma Medications During Pregnancy
2.2 Market Analysis by Application
2.2.1 Children
2.2.2 Adolescent
2.2.3 Adult
2.3 Global Asthma Medication Market Comparison by Regions (2017-2027)
2.3.1 Global Asthma Medication Market Size (2017-2027)
2.3.2 North America Asthma Medication Status and Prospect (2017-2027)
2.3.3 Europe Asthma Medication Status and Prospect (2017-2027)
2.3.4 China Asthma Medication Status and Prospect (2017-2027)
2.3.5 Japan Asthma Medication Status and Prospect (2017-2027)
2.3.6 Southeast Asia Asthma Medication Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Asthma Medication Industry Impact
2.5.1 Asthma Medication Business Impact Assessment - Covid-19
2.5.2 Market Trends and Asthma Medication Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Asthma Medication Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Asthma Medication Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Asthma Medication Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Asthma Medication Manufacturer Market Share
3.5 Top 10 Asthma Medication Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Asthma Medication Market
3.7 Key Manufacturers Asthma Medication Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Asthma Medication Industry Key Manufacturers
4.1 Dulera
4.1.1 Compan Detail
4.1.2 Dulera Asthma Medication Product Introduction, Application and Specification
4.1.3 Dulera 161 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 Dulera News
4.2 QVAR
4.2.1 Compan Detail
4.2.2 QVAR Asthma Medication Product Introduction, Application and Specification
4.2.3 QVAR Asthma Medication Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 Dulera News
4.3 Glaxosmithkline plc
4.3.1 Compan Detail
4.3.2 Glaxosmithkline plc Asthma Medication Product Introduction, Application and Specification
4.3.3 Glaxosmithkline plc Asthma Medication Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Glaxosmithkline plc News
4.4 MAP Pharmaceuticals,Inc
4.4.1 Compan Detail
4.4.2 MAP Pharmaceuticals,Inc Asthma Medication Product Introduction, Application and Specification
4.4.3 MAP Pharmaceuticals,Inc Asthma Medication Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 MAP Pharmaceuticals,Inc News
4.5 Merck & Co. Inc
4.5.1 Compan Detail
4.5.2 MAP Pharmaceuticals,Inc Asthma Medication Product Introduction, Application and Specification
4.5.3 Merck & Co. Inc Asthma Medication Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Merck & Co. Inc News
4.6 AstraZeneca plc
4.6.1 Compan Detail
4.6.2 AstraZeneca plc Asthma Medication Product Introduction, Application and Specification
4.6.3 AstraZeneca plc Asthma Medication Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 AstraZeneca plc News
4.7 Roche Holdings Ltd
4.7.1 Compan Detail
4.7.2 Roche Holdings Ltd Asthma Medication Product Introduction, Application and Specification
4.7.3 Roche Holdings Ltd Asthma Medication Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Genentech Inc
4.8.1 Compan Detail
4.8.2 Genentech Inc Asthma Medication Product Introduction, Application and Specification
4.8.3 Genentech Inc Asthma Medication Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Genentech Inc News
4.9 Sepracor, Inc
4.9.1 Compan Detail
4.9.2 Sepracor, Inc Asthma Medication Product Introduction, Application and Specification
4.9.3 Sepracor, Inc Asthma Medication Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Sepracor, Inc News
4.10 Schering-Plough Corp
4.10.1 Compan Detail
4.10.2 Schering-Plough Corp Asthma Medication Product Introduction, Application and Specification
4.10.3 Schering-Plough Corp Asthma Medication Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Schering-Plough Corp News
4.11 Sanofi-Aventis
4.11.1 Compan Detail
4.11.2 Sanofi-Aventis Asthma Medication Product Introduction, Application and Specification
4.11.3 Sanofi-Aventis Asthma Medication Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Sanofi-Aventis News
4.12 Theravance Inc
4.12.1 Compan Detail
4.12.2 Theravance Inc Asthma Medication Product Introduction, Application and Specification
4.12.3 Theravance Inc Asthma Medication Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Theravance Inc News
5 Global Asthma Medication Market Segment by Big Type
5.1 Global Asthma Medication Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Asthma Medication Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Asthma Medication Revenue and Market Share by Big Type (2017-2022)
5.2 Quick-Relief Medications Sales Growth Rate and Price
5.2.1 Global Quick-Relief Medications Sales Growth Rate (2017-2022)
5.2.2 Global Quick-Relief Medications Price (2017-2022)
5.3 Long-Term Control Medications Sales Growth Rate and Price
5.3.1 Global Long-Term Control Medications Sales Growth Rate (2017-2022)
5.3.2 Global Long-Term Control Medications Price (2017-2022)
5.4 Asthma Medications During Pregnancy Sales Growth Rate and Price
5.4.1 Global Asthma Medications During Pregnancy Sales Growth Rate (2017-2022)
5.4.2 Global Asthma Medications During Pregnancy Price (2017-2022)
6 Global Asthma Medication Market Segment by Big Application
6.1 Global Asthma Medication Sales Market Share by Big Application (2017-2022)
6.2 Children Sales Growth Rate (2017-2022)
6.3 Adolescent Sales Growth Rate (2017-2022)
6.4 Adult Sales Growth Rate (2017-2022)
7 Global Asthma Medication Forecast
7.1 Global Asthma Medication Revenue, Sales and Growth Rate (2022-2027)
7.2 Asthma Medication Market Forecast by Regions (2022-2027)
7.2.1 North America Asthma Medication Market Forecast (2022-2027)
7.2.2 Europe Asthma Medication Market Forecast (2022-2027)
7.2.3 China Asthma Medication Market Forecast (2022-2027)
7.2.4 Japan Asthma Medication Market Forecast (2022-2027)
7.2.5 Southeast Asia Asthma Medication Market Forecast (2022-2027)
7.2.6 Other Regions Asthma Medication Market Forecast (2022-2027)
7.3 Asthma Medication Market Forecast by Type (2022-2027)
7.3.1 Global Asthma Medication Sales Forecast by Type (2022-2027)
7.3.2 Global Asthma Medication Market Share Forecast by Type (2022-2027)
7.4 Asthma Medication Market Forecast by Application (2022-2027)
7.4.1 Global Asthma Medication Sales Forecast by Application (2022-2027)
7.4.2 Global Asthma Medication Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Asthma Medication Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Asthma Medication Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Asthma Medication
Figure Market Concentration Ratio and Market Maturity Analysis of Asthma Medication
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Asthma Medication Market Size by Big Type
Figure Global Market Share of Asthma Medication by Big Type in 2021
Figure Quick-Relief Medications Picture (2017-2022)
Figure Long-Term Control Medications Picture (2017-2022)
Global Asthma Medication Market Size by Big Application
Table Global Asthma Medication Market Size by Application
Figure Global Asthma Medication Market Share by Big Application in 2021
Figure Children Picture
Figure Adolescent Picture
Figure Adult Picture
Table Global Asthma Medication Comparison by Regions (M USD) (2017-2027)
Figure Global Asthma Medication Market Size (Million US$) (2017-2027)
Figure North America Asthma Medication Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Asthma Medication Revenue (Million US$) Growth Rate (2017-2027)
Figure China Asthma Medication Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Asthma Medication Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Asthma Medication Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Asthma Medication Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Asthma Medication Sales by Manufacturer (2017-2022)
Figure Global Asthma Medication Sales Market Share by Manufacturer in 2021
Table Global Asthma Medication Revenue by Manufacturer (2017-2022)
Figure Global Asthma Medication Revenue Market Share by Manufacturer in 2021
Table Global Asthma Medication Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Asthma Medication Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Asthma Medication Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Asthma Medication Market
Table Key Manufacturers Asthma Medication Product Type
Table Mergers & Acquisitions Planning
Table Dulera Company Profile
Table Asthma Medication Product Introduction, Application and Specification of Dulera
Table Asthma Medication Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table QVAR Company Profile
Table Asthma Medication Product Introduction, Application and Specification of QVAR
Table Asthma Medication Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table QVAR Recent Development
Table Glaxosmithkline plc Company Profile
Table Asthma Medication Product Introduction, Application and Specification of Glaxosmithkline plc
Table Asthma Medication Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Glaxosmithkline plc Main Business
Table Glaxosmithkline plc Recent Development
Table MAP Pharmaceuticals,Inc Company Profile
Table Asthma Medication Product Introduction, Application and Specification of MAP Pharmaceuticals,Inc
Table Asthma Medication Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table MAP Pharmaceuticals,Inc Main Business
Table MAP Pharmaceuticals,Inc Recent Development
Table MAP Pharmaceuticals,Inc Main Business
Table MAP Pharmaceuticals,Inc Recent Development
Table Merck & Co. Inc Company Profile
Table Asthma Medication Product Introduction, Application and Specification of Merck & Co. Inc
Table Asthma Medication Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Merck & Co. Inc Main Business
Table Merck & Co. Inc Recent Development
Table AstraZeneca plc Company Profile
Table Asthma Medication Product Introduction, Application and Specification of AstraZeneca plc
Table Asthma Medication Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table AstraZeneca plc Main Business
Table AstraZeneca plc Recent Development
Table Roche Holdings Ltd Company Profile
Table Asthma Medication Product Introduction, Application and Specification of Roche Holdings Ltd
Table Asthma Medication Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Roche Holdings Ltd Main Business
Table Roche Holdings Ltd Recent Development
Table Genentech Inc Company Profile
Table Asthma Medication Product Introduction, Application and Specification of Genentech Inc
Table Asthma Medication Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Genentech Inc Main Business
Table Genentech Inc Recent Development
Table Sepracor, Inc Company Profile
Table Asthma Medication Product Introduction, Application and Specification of Sepracor, Inc
Table Asthma Medication Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sepracor, Inc Main Business
Table Sepracor, Inc Recent Development
Table Schering-Plough Corp Company Profile
Table Asthma Medication Product Introduction, Application and Specification of Schering-Plough Corp
Table Asthma Medication Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Schering-Plough Corp Main Business
Table Schering-Plough Corp Recent Development
Table Sanofi-Aventis Company Profile
Table Asthma Medication Product Introduction, Application and Specification of Sanofi-Aventis
Table Asthma Medication Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sanofi-Aventis Main Business
Table Sanofi-Aventis Recent Development
Table Theravance Inc Company Profile
Table Asthma Medication Product Introduction, Application and Specification of Theravance Inc
Table Asthma Medication Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Theravance Inc Main Business
Table Theravance Inc Recent Development
Figure Global Asthma Medication Sales and Growth Rate (2017-2022)
Figure Global Asthma Medication Revenue and Growth Rate (2017-2022)
Table Global Asthma Medication Sales by Regions (2017-2022)
Figure Global Asthma Medication Sales Market Share by Regions in 2021
Table Global Asthma Medication Revenue by Regions (2017-2022)
Figure Global Asthma Medication Revenue Market Share by Regions in 2021
Figure North America Asthma Medication Sales and Growth Rate (2017-2022)
Figure Europe Asthma Medication Sales and Growth Rate (2017-2022)
Figure China Asthma Medication Sales and Growth Rate (2017-2022)
Figure Japan Asthma Medication Sales and Growth Rate (2017-2022)
Figure Southeast Asia Asthma Medication Sales and Growth Rate (2017-2022)
Figure Other Regions Asthma Medication Sales and Growth Rate (2017-2022)
Table Global Asthma Medication Sales by Big Type (2017-2022)
Table Global Asthma Medication Sales Market Share by Big Type (2017-2022)
Figure Global Asthma Medication Sales Market Share by Big Type in 2019
Table Global Asthma Medication Revenue by Big Type (2017-2022)
Table Global Asthma Medication Revenue Market Share by Big Type (2017-2022)
Table Global Asthma Medication Revenue Market Share by Big Type in 2019
Figure Global Quick-Relief Medications Sales Growth Rate (2017-2022)
Figure Global Quick-Relief Medications Price (2017-2022)
Figure Global Long-Term Control Medications Sales Growth Rate (2017-2022)
Figure Global Long-Term Control Medications Price (2017-2022)
Figure Global Asthma Medications During Pregnancy Sales Growth Rate (2017-2022)
Table Global Asthma Medication Sales by Big Application (2017-2022)
Table Global Asthma Medication Sales Market Share by Big Application (2017-2022)
Figure Global Asthma Medication Sales Market Share by Big Application in 2019
Figure Global Children Sales Growth Rate (2017-2022)
Figure Global Adolescent Sales Growth Rate (2017-2022)
Figure Global Adult Sales Growth Rate (2017-2022)
Figure Global Asthma Medication Sales and Growth Rate (2022-2027)
Figure Global Asthma Medication Revenue and Growth Rate (2022-2027)
Table Global Asthma Medication Sales Forecast by Regions (2022-2027)
Table Global Asthma Medication Market Share Forecast by Regions (2022-2027)
Figure North America Sales Asthma Medication Market Forecast (2022-2027)
Figure Europe Sales Asthma Medication Market Forecast (2022-2027)
Figure China Sales Asthma Medication Market Forecast (2022-2027)
Figure Japan Sales Asthma Medication Market Forecast (2022-2027)
Figure Southeast Asia Sales Asthma Medication Market Forecast (2022-2027)
Figure Other Regions Sales Asthma Medication Market Forecast (2022-2027)
Table Global Asthma Medication Sales Forecast by Type (2022-2027)
Table Global Asthma Medication Market Share Forecast by Type (2022-2027)
Table Global Asthma Medication Sales Forecast by Application (2022-2027)
Table Global Asthma Medication Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Asthma Medication
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Asthma Medication Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Asthma Medication Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Asthma Medication Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Asthma Medication Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Asthma Medication Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Asthma Medication Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Asthma Medication Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Asthma Medication Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)